Haas Jason - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 18, 2024, Haas Jason's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Officer (Chief Financial Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Haas Jason - Insider Non-Derivative Transactions of SYRS Common Stock

Haas Jason - Insider Non-Derivative Transactions at SYRS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 19, 2024	Sell -- (Common Stock)	137803	0.21	0
Nov 1, 2024	F -- (Common Stock)	5624	2.09	137803
Nov 1, 2024	M -- (Common Stock)	18875	0	143427
Sep 13, 2024	P -- (Common Stock)	45344	1.68	124552
Sep 12, 2024	P -- (Common Stock)	19293	1.58	79208
Sep 11, 2024	P -- (Common Stock)	35363	1.55	59915
Apr 2, 2024	F -- (Common Stock)	4732	5.12	24552
Apr 1, 2024	M -- (Common Stock)	2000	0	15951
Apr 1, 2024	M -- (Common Stock)	13333	0	29284
Nov 2, 2023	F -- (Common Stock)	6301	2.22	13951
Nov 1, 2023	M -- (Common Stock)	18875	0	20252
Apr 4, 2023	F -- (Common Stock)	623	2.58	1377
Apr 1, 2023	M -- (Common Stock)	2000	0	2000